Morning Market Losers

By: via Benzinga
Clovis Oncology Inc (NASDAQ: CLVS) shares dropped 70.65 percent to $29.18 following report of the FDA request for additional ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.